Detalles de la búsqueda
1.
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.
J Hepatol
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428641
2.
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis.
Liver Int
; 44(2): 279-285, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100141
3.
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Gastroenterol Hepatol
; 46(10): 764-773, 2023 Dec.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-36731726
4.
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study.
Gastroenterology
; 160(4): 1151-1163.e3, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33307029
5.
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.
Liver Transpl
; 28(6): 1039-1050, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919762
6.
Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
Ann Hepatol
; 27(3): 100687, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192963
7.
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study.
Gut
; 70(10): 1914-1924, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281984
8.
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.
Am J Transplant
; 21(8): 2876-2884, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835707
9.
A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.
J Hepatol
; 75(2): 275-283, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33746085
10.
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.
J Hepatol
; 74(1): 148-155, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750442
11.
Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
Transpl Int
; 34(10): 1908-1913, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121244
12.
Secondary syphilis with liver involvement in a liver transplant recipient.
Transpl Infect Dis
; 23(1): e13431, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738832
13.
Routine Bile Culture From Liver Donors as Screening of Donor-Transmitted Infections in Liver Transplantation.
Liver Transpl
; 26(9): 1121-1126, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32289870
14.
Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Liver Int
; 40(8): 1906-1916, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32329119
15.
Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature.
Transpl Infect Dis
; 21(3): e13072, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865352
16.
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
Am J Transplant
; 18(10): 2513-2522, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29963780
17.
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
J Hepatol
; 69(1): 11-17, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481821
18.
Sofosbuvir/velpatasvir for 12â¯weeks in genotype 1-4 HCV-infected liver transplant recipients.
J Hepatol
; 69(3): 603-607, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29886154
19.
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.
Hepatology
; 65(6): 1810-1822, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28170112
20.
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
Liver Int
; 38(11): 1940-1950, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29660249